TRIGENESIS Trademark

Trademark Overview


On Wednesday, December 9, 2020, a trademark application was filed for TRIGENESIS with the United States Patent and Trademark Office. The USPTO has given the TRIGENESIS trademark a serial number of 90369578. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, November 7, 2022. This trademark is owned by Sarepta Therapeutics, Inc.. The TRIGENESIS trademark is filed in the Paper & Printed Material Products, Computer & Software Services & Scientific Services, and Medical & Beauty Services & Agricultural Services categories with the following description:

Printed materials, namely, brochures, leaflets, reports, and newsletters on the topics of medicine, medical research, scientific research, research and development of pharmaceuticals, biological preparations and gene therapy products, rare diseases, neuromuscular diseases and disorders, muscular dystrophies, central nervous system diseases and disorders, genetic diseases and disorders, genetic therapy research, and diagnosis and treatment of genetic disorders

Medical information services, namely, providing information relating to medicine, rare diseases, neuromuscular diseases and disorders, muscular dystrophies, central nervous system diseases and disorders, genetic diseases and disorders, and diagnosis and treatment of genetic disorders; Providing medical information via a website in the field of medicine, diseases, neuromuscular diseases and disorders, muscular dystrophies, central nervous system diseases and disorders, genetic diseases and disorders, and diagnosis and treatment of genetic disorders; Providing medical information to doctors and patients regarding rare diseases, medicines, health conditions and treatment options

Medical research; medical and scientific research services all in the field of rare diseases; medical and scientific research services all in the field of neuromuscular diseases and disorders, muscular dystrophies, central nervous system diseases and disorders, and genetic diseases and disorders; medical and scientific research services all in the field of gene therapy, gene editing, genome editing, viruses, viral vectors, and viral constructs; providing information relating to medical research, scientific research, research and development of pharmaceuticals, biological preparations and gene therapy products, and medical research in the field of genetic therapy; providing information via a website in the field of medical research, scientific research, research and development of pharmaceuticals, biological preparations and gene therapy products, and medical research in the field of genetic therapy
trigenesis

General Information


Serial Number90369578
Word MarkTRIGENESIS
Filing DateWednesday, December 9, 2020
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, November 7, 2022
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing3000 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, February 8, 2022

Trademark Statements


Description of MarkThe mark consists of a dot and two dashes with the word "TRIGENESIS" underneath.
Goods and ServicesPrinted materials, namely, brochures, leaflets, reports, and newsletters on the topics of medicine, medical research, scientific research, research and development of pharmaceuticals, biological preparations and gene therapy products, rare diseases, neuromuscular diseases and disorders, muscular dystrophies, central nervous system diseases and disorders, genetic diseases and disorders, genetic therapy research, and diagnosis and treatment of genetic disorders
Goods and ServicesMedical information services, namely, providing information relating to medicine, rare diseases, neuromuscular diseases and disorders, muscular dystrophies, central nervous system diseases and disorders, genetic diseases and disorders, and diagnosis and treatment of genetic disorders; Providing medical information via a website in the field of medicine, diseases, neuromuscular diseases and disorders, muscular dystrophies, central nervous system diseases and disorders, genetic diseases and disorders, and diagnosis and treatment of genetic disorders; Providing medical information to doctors and patients regarding rare diseases, medicines, health conditions and treatment options
Goods and ServicesMedical research; medical and scientific research services all in the field of rare diseases; medical and scientific research services all in the field of neuromuscular diseases and disorders, muscular dystrophies, central nervous system diseases and disorders, and genetic diseases and disorders; medical and scientific research services all in the field of gene therapy, gene editing, genome editing, viruses, viral vectors, and viral constructs; providing information relating to medical research, scientific research, research and development of pharmaceuticals, biological preparations and gene therapy products, and medical research in the field of genetic therapy; providing information via a website in the field of medical research, scientific research, research and development of pharmaceuticals, biological preparations and gene therapy products, and medical research in the field of genetic therapy

Classification Information


International Class016 - Paper, cardboard and goods made from these materials, not included in other classes; printed matter; bookbinding material; photographs; stationery; adhesives for stationery or household purposes; artists' materials; paint brushes; typewriters and office requisites (except furniture); instructional and teaching material (except apparatus); plastic materials for packaging (not included in other classes); printers' type; printing blocks.
US Class Codes002, 005, 022, 023, 029, 037, 038, 050
Class Status Code6 - Active
Class Status DateTuesday, February 16, 2021
Primary Code016
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateTuesday, February 16, 2021
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateTuesday, February 16, 2021
Primary Code044
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameSarepta Therapeutics, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressCambridge, MA 02142

Party NameSarepta Therapeutics, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressCambridge, MA 02142

Trademark Events


Event DateEvent Description
Monday, November 7, 2022ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, November 7, 2022ABANDONMENT - NO USE STATEMENT FILED
Tuesday, April 5, 2022NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, February 8, 2022OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, February 8, 2022PUBLISHED FOR OPPOSITION
Wednesday, January 19, 2022NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, January 4, 2022APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, January 4, 2022EXAMINER'S AMENDMENT ENTERED
Tuesday, January 4, 2022NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Tuesday, January 4, 2022EXAMINERS AMENDMENT E-MAILED
Tuesday, January 4, 2022EXAMINERS AMENDMENT -WRITTEN
Thursday, December 2, 2021TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, December 2, 2021CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, December 2, 2021TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, June 2, 2021NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, June 2, 2021NON-FINAL ACTION E-MAILED
Wednesday, June 2, 2021NON-FINAL ACTION WRITTEN
Saturday, May 29, 2021ASSIGNED TO EXAMINER
Wednesday, February 17, 2021NOTICE OF DESIGN SEARCH CODE E-MAILED
Tuesday, February 16, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Saturday, December 12, 2020NEW APPLICATION ENTERED IN TRAM